多发性硬化症神经治疗,神经保护和风险缓解策略的进展
Ahmad Abdelrahman1, Enrique Alvarez2
1Department of Neurology, Rocky Mountain MS Center at the University of Colorado Anschutz Medical Center, Aurora, CO, USA.
Neurologic clinics
|November 18, 2023
概括
新的疾病修饰疗法显著减少复发性多发性硬化症 (MS) 的炎症. 风险减轻策略,包括降低治疗升级和停止治疗,改善MS患者的安全性和益处风险平衡.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 神经科学是一个神经科学.
背景情况:
- 多发性硬化症 (MS) 治疗已经进步,新的疗法有效地减少复发性复发性炎症.
- 尽管取得了进展,但控制渐进性多发性硬化和实现神经修复仍然是挑战.
- 神经保护对于管理多发性硬化症至关重要,特别是考虑到渐进形式的限制.
研究的目的:
- 审查目前用于复发性MS的神经治疗方法.
- 专注于应用新的疾病修饰治疗方法.
- 讨论减轻治疗风险和优化利益风险平衡的策略.
主要方法:
- 关于MS治疗的最新进展的文献综述.
- 对复发性多发性硬化症的新型疾病修饰性治疗方法的分析.
- 讨论风险减轻策略,包括降级和停止.
主要成果:
- 最近的疗法可显著减少复发性多发性硬化症的炎症过程.
- 风险减轻策略可以提高MS药物的安全性.
- 停止治疗和降低风险是风险管理的关键组成部分.
结论:
- 多发性硬化症治疗的不断变化的格局强调有效的炎症控制.
- 通过仔细管理优化利益风险比是必不可少的.
- 神经保护和治疗渐进性多发性硬化症需要持续的研究和治疗开发.
相关概念视频
00:49The Blood-brain Barrier
47.4K
Overview
47.4K
01:15Parkinson's Disease: Overview
560
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
560
01:22Alzheimer's Disease: Treatment
196
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
196